Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|4|1|21-37

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.4, Iss.1, 2003-02, pp. : 21-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-Dependent Kinase Inhibition by Flavoalkaloids

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 7, 2012-06 ,pp. : 632-649

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Research in Selective Cyclin-Dependent Kinase 4 Inhibitors for Anti-Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 16, Iss. 36, 2009-12 ,pp. : 4869-4888

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent protein kinases as therapeutic targets in cardiovascular disease

By Edo María Dolores   Roldán Marta   Andrés Vicente  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 5, 2003-05 ,pp. : 579-588

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibitors: Cancer Killers to Neuronal Guardians

By  

Current Medicinal Chemistry, Vol. 10, Iss. 5, 2003-03 ,pp. : 367-379

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

By Bose Prithviraj   Simmons Gary L   Grant Steven  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 723-738

Informa Healthcare

Access to resources Recommend Favorite